SCI时时刷

search
+
Shift in perspective: autoimmunity protecting against rheumatoid arthritis
Shift in perspective: autoimmunity protecting against rheumatoid arthritis
A hallmark of rheumatoid arthritis (RA) is the increased levels of autoantibodies preceding the onset and contributing to ...
Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis
Comorbidity clusters in patients with rheumatoid arthritis identify a patient phenotype with a favourable prognosis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3
EPO promotes the progression of rheumatoid arthritis by inducing desialylation via increasing the expression of neuraminidase 3
WHAT IS ALREADY KNOWN ON THIS TOPICAnaemia occurs in 30%–70% of patients with rheumatoid arthritis (RA), which leads to th...
Goodbye to the term 'ankylosing spondylitis, hello 'axial spondyloarthritis: time to embrace the ASAS-defined nomenclature
Goodbye to the term 'ankylosing spondylitis, hello 'axial spondyloarthritis: time to embrace the ASAS-defined nomenclature
Ankylosing spondylitis (AS) is the historic term used for decades for the HLA-B27-associated inflammatory disease affectin...
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-{alpha} in rheumatoid arthritis
Proinflammatory phenotype of B10 and B10pro cells elicited by TNF-{alpha} in rheumatoid arthritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort
Can rheumatologists unequivocally diagnose axial spondyloarthritis in patients with chronic back pain of less than 2 years duration? Primary outcome of the 2-year SPondyloArthritis Caught Early (SPACE) cohort
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis
Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types
Deep immunophenotyping reveals that autoimmune and autoinflammatory disorders are spread along two immunological axes capturing disease inflammation levels and types
IntroductionAutoimmune diseases (AD) and autoinflammatory diseases (AIF) are pathological conditions arising from the imba...
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial
Comparison of the effect of treatment with NSAIDs added to anti-TNF therapy versus anti-TNF therapy alone on the progression of structural damage in the spine over 2 years in patients with radiographic axial spondyloarthritis from the randomised-controlled CONSUL trial
WHAT IS ALREADY KNOWN ON THIS TOPICContinuous intake of celecoxib over 2 years was associated with retardation of radiogra...
Prognostic model to predict the incidence of radiographic knee osteoarthritis
Prognostic model to predict the incidence of radiographic knee osteoarthritis
IntroductionOsteoarthritis (OA) is one of the most prevalent and disabling rheumatic diseases, and therefore, causes a sig...
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial
Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Vasculitis that did not read the books
Vasculitis that did not read the books
A 29-year-old woman presented to our rheumatology clinic with a 6-month history of cough, dysphonia, dyspnoea and weight l...
Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibility
Associations of residential greenness with bone mineral density and osteoporosis: the modifying effect of genetic susceptibility
WHAT IS ALREADY KNOWN ON THIS TOPICOsteoporosis is a complex disease caused by both genetic and environmental factors.The ...
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study
Immunomodulators and risk for breakthrough COVID-19 after third SARS-CoV-2 mRNA vaccine among patients with rheumatoid arthritis: a cohort study
The US Centers for Disease Control and Prevention (CDC) recommends three SARS-CoV-2 messenger ribonucleic acid (mRNA) vacc...
Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts
Validation of the definition of rheumatoid arthritis flare based on SDAI and CDAI in clinical practice in two French independent cohorts
New definitions for flares in rheumatoid arthritis (RA) based on the Simplified and Clinical Disease Activity Indices (SDA...
Correction: Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
Correction: Lupus low disease activity state attainment in the phase 3 TULIP trials of anifrolumab in active systemic lupus erythematosus
Morand EF, Abreu G, Furie RA, et al. Lupus low disease activity state attainment in the phase 3 TULIP trials of anifroluma...
Gender imbalance in expert panels of recommendations in rheumatology
Gender imbalance in expert panels of recommendations in rheumatology
Gender imbalance is a major source of inequity in the society. Inequality is an enduring topic also in medical research, a...
Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
Single-cell transcriptome analyses reveal disturbed decidual homoeostasis in obstetric antiphospholipid syndrome
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023
Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2023
The Advances in Targeted Therapies meets annually, convening experts in the field of rheumatology to both provide scientif...
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis
No effective treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD) exists. Numerous evidences sup...
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion
CD7 activation regulates cytotoxicity-driven pathology in systemic sclerosis, yielding a target for selective cell depletion
IntroductionSystemic sclerosis (SSc) is a systemic autoimmune disease that is characterised by vasculopathy, inflammation ...
Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
Low plasma belimumab levels as an indicator of poor adherence to belimumab in patients with systemic lupus erythematosus
Non-adherence is a significant issue in the treatment of systemic lupus erythematosus (SLE), associated with the risks of ...
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot study)
Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the 'JAK-pot study)
IntroductionRheumatoid arthritis (RA) is a chronic autoimmune disorder that causes inflammation in the joints, leading to ...
Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
Lower body mass and lower adiposity are associated with differential responses to two treatment strategies for rheumatoid arthritis
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial
Effectiveness of longstanding exercise therapy compared with usual care for people with rheumatoid arthritis and severe functional limitations: a randomised controlled trial
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Cleara...
Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients
Male patients with inflammatory joint diseases are less likely than controls to be childless: results from a Norwegian population-based cohort study of 10 865 patients
WHAT IS ALREADY KNOWN ON THIS TOPICThere are limited data regarding fertility in male patients with inflammatory joint dis...
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Mortality in patients with psoriatic arthritis in Sweden: a nationwide, population-based cohort study
Main findingsIn this large, nationwide, population-based, 12-year, cohort study (PsA cases, n=33 026), the all-cause morta...
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial
IntroductionSystemic lupus erythematosus (SLE) is a heterogeneous and biologically complex autoimmune disease that can lea...
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
Pragmatic targets for moderate/severe SLE and their implications for clinical care and trial design: sustained DORIS or LLDAS for at least 6 months is sufficient while their attainment for at least 24 months ensures high specificity for damage-free progression
IntroductionThe treat-to-target paradigm has been successfully applied to many chronic conditions, including inflammatory ...
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury
CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury
WHAT IS ALREADY KNOWN ON THIS TOPICHOW THIS STUDY MIGHT AFFECT RESEARCH, PRACTICE OR POLICYIntroductionAnti-neutrophil cyt...
阅读更多
format_indent_increase